Developing innovative medicines to help address pressing public health challenges – #mentalillness, #addiction & #cancer. Guidelines: http://bit.ly/2SFh3wy
Location: Ireland, Dublin City, Dublin
Employees: 1001-5000
Founded date: 1987
Investors 2
Date | Name | Website |
26.10.2022 | Internatio... | ibtplc.com |
- | Cardinal P... | cardinalpa... |
Mentions in press and media 30
Date | Title | Description | Source |
12.03.2024 | Opioid Use Disorder Market to Reach USD 6.15 Billion by 2030... | Opioid Use Disorder (OUD) Market Opioid Use Disorder Market Analysis, Industry Trends and Growth Out... | einpresswi... |
16.10.2023 | How is Revolutionary Biotech Transforming Chronic Disease Tr... | Key Takeaways: Alkermes is a Dublin-based biotech startup that develops, manufactures, and commercia... | eustartup.... |
08.05.2023 | Alkermes Files Preliminary Proxy Statement and Provides Upda... | DUBLIN, May 8, 2023 /PRNewswire/ -- Alkermes plc ALKS today filed its preliminary proxy statement wi... | einpresswi... |
03.05.2023 | WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaph... | BOSTON (PRWEB) May 03, 2023 The Melanoma Research Foundation (MRF) is thrilled to announce that WCVB... | prweb.com/... |
06.01.2022 | New National Survey of People Living with Bipolar I Disorder... | DUBLIN, Jan. 6, 2022 /PRNewswire/ -- Results from a newly released survey provide insights from adul... | marketscre... |
27.10.2021 | Q3 2021 Earnings slides 10 26 21 FINAL_v3.pdf | Third Quarter 2021 Financial Results & Business Update October 27, 2021 © 2021 Alkermes. All rig... | marketscre... |
09.09.2021 | Alkermes Announces Launch of 4th Annual Alkermes Pathways Re... | prnewswire... | |
02.08.2021 | Alkermes Receives FDA Fast Track Designation for Nemvaleukin... | prnewswire... | |
28.07.2021 | Alkermes plc Reports Second Quarter 2021 Financial Results ... | prnewswire... | |
26.07.2021 | Alkermes : Announces Recipients of 2021 Alkermes Inspiration... | DUBLIN - Alkermes plc (Nasdaq: ALKS) announced the 2021 recipients of grants from the company's sign... | marketscre... |
Show more